12,125
Views
64
CrossRef citations to date
0
Altmetric
Reviews

Progress in HIV vaccine development

& , MD
Pages 1018-1030 | Received 16 Nov 2016, Accepted 20 Dec 2016, Published online: 10 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Joseph Jelinski, Monika M. Kowatsch, Marc-Alexandre Lafrance, Alice Berger, Jannie Pedersen, Hiva Azizi, Yue Li, Florine Scholte, Alejandro Gomez, Natasha Hollett, Toby Le, Matthew Wade, Hugues Fausther-Bovendo, Marc-Antoine de La Vega, George Babuadze, Ara XIII, Claude Lamarre, Trina Racine, Chil-Yong Kang, Xiao-Jian Yao, Galit Alter, Eric Arts, Keith R. Fowke & Gary P. Kobinger. (2023) Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen. Emerging Microbes & Infections 12:2.
Read now
Christopher P. Karch & Gary R. Matyas. (2021) The current and future role of nanovaccines in HIV-1 vaccine development. Expert Review of Vaccines 20:8, pages 935-944.
Read now
Carl R. Alving, Kristina K. Peachman, Gary R. Matyas, Mangala Rao & Zoltan Beck. (2020) Army Liposome Formulation (ALF) family of vaccine adjuvants. Expert Review of Vaccines 19:3, pages 279-292.
Read now
Qian Wang, Bingting Ma, Qingtai Liang, Angqi Zhu, Hua Wang, Lili Fu, Xiaoxu Han, Xuanling Shi, Ye Xiang, Hong Shang & Linqi Zhang. (2020) Stabilized diverse HIV-1 envelope trimers for vaccine design. Emerging Microbes & Infections 9:1, pages 775-786.
Read now
Jean-Louis Excler & Jerome H. Kim. (2019) Novel prime-boost vaccine strategies against HIV-1. Expert Review of Vaccines 18:8, pages 765-779.
Read now

Articles from other publishers (59)

Garima Sahu, Priyanka Kumari & Amit K. Goyal. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery 15 62 .
Massimiliano Bissa, Veronica Galli, Luca Schifanella, Monica Vaccari, Mohammad Arif Rahman, Giacomo Gorini, Nicolò Binello, Sarkis Sarkis, Anna Gutowska, Isabela Silva de Castro, Melvin N. Doster, Ramona Moles, Guido Ferrari, Xiaoying Shen, Georgia D. Tomaras, David C. Montefiori, Kombo F. N’guessan, Dominic Paquin-Proulx, Pamela A. Kozlowski, David J. Venzon, Hyoyoung Choo-Wosoba, Matthew W. Breed, Joshua Kramer & Genoveffa Franchini. (2023) In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells. Vaccines 11:11, pages 1662.
Crossref
Beatriz Perdiguero, Patricia Pérez, Laura Marcos-Villar, Guillermo Albericio, David Astorgano, Enrique Álvarez, Laura Sin, Carmen Elena Gómez, Juan García-Arriaza & Mariano Esteban. (2023) Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases. Journal of Molecular Biology 435:15, pages 168173.
Crossref
Dylan Hull-Nye, Tyler Meadows, Stacey R. Smith? & Elissa J. Schwartz. (2023) Key Factors and Parameter Ranges for Immune Control of Equine Infectious Anemia Virus Infection. Viruses 15:3, pages 691.
Crossref
Cordin ArpagausCordin Arpagaus. 2023. Spray Drying of Vaccines. Spray Drying of Vaccines 325 530 .
Paballo Nkone, Shayne Loubser, Thomas C. Quinn, Andrew D. Redd, Arshad Ismail, Caroline T. Tiemessen & Simnikiwe H. Mayaphi. (2022) Deep sequencing of the HIV-1 polymerase gene for characterisation of cytotoxic T-lymphocyte epitopes during early and chronic disease stages. Virology Journal 19:1.
Crossref
Wan-Rong Luo, Xiao-Min Wu, Wei Wang, Jun-Ling Yu, Qing-Qing Chen, Xue Zhou, Xin'er Huang, Hai-Feng Pan, Zhi-Rong Liu, Yong Gao & Jun He. (2022) Novel coronavirus mutations: Vaccine development and challenges. Microbial Pathogenesis 173, pages 105828.
Crossref
Jianru Qin, Bing Hu, Qiqi Song, Ruijuan Wang, Xiangfei Zhang, Yaqi Yu & Jian-Hua Wang. (2022) The transmembrane replacement H7N9-VLP vaccine displays high levels of protection in mice. Frontiers in Microbiology 13.
Crossref
Omolayo Fatola, Amy Corneli, Brian Perry, Emily Hanlen-Rosado, Adora Nsonwu, Evangelia P Constantine & Amelia B Thompson. (2022) “An Extra Variable to Consider”—Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. Journal of the Pediatric Infectious Diseases Society 11:5, pages 221-224.
Crossref
N. B. Rudometova, D. N. Shcherbakov, A. P. Rudometov, A. A. Ilyichev & L. I. Karpenko. (2022) Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1. Vavilov Journal of Genetics and Breeding 26:2, pages 214-221.
Crossref
Marisierra Espinar-Buitrago & Ma Angeles Muñoz-Fernández. (2022) New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection. Frontiers in Immunology 12.
Crossref
Susan Pereira Ribeiro, Vania Gomes De Moura Mattaraia, Rafael Ribeiro Almeida, Elizabeth Juliana Ghiuro Valentine, Natiely Silva Sales, Luís Carlos S. Ferreira, Luiz Carlos Sa-Rocha, Lucas Cauê Jacintho, Vinicius Canato Santana, John Sidney, Alessandro Sette, Daniela Santoro Rosa, Jorge Kalil & Edecio Cunha-Neto. (2022) A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates. Vaccine 40:2, pages 239-246.
Crossref
Agatha K. Bula, Kendra Hatfield-Timajchy, John Chapola, L. Chinula, Stacey A. Hurst, Athena P. Kourtis & J. H. Tang. (2021) Motivations to use hormonal contraceptive methods and condoms among HIV-positive and negative women randomized to a progestin contraceptive in Malawi: a qualitative study. BMC Women's Health 21:1.
Crossref
Kathrin U. Jansen, William C. Gruber, Raphael Simon, James Wassil & Annaliesa S. Anderson. (2021) The impact of human vaccines on bacterial antimicrobial resistance. A review. Environmental Chemistry Letters 19:6, pages 4031-4062.
Crossref
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil & Homa Darmani. (2021) The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines. Cellular Immunology 369, pages 104440.
Crossref
Anna Hargrave, Abu Salim Mustafa, Asma Hanif, Javed H. Tunio & Shumaila Nida M. Hanif. (2021) Current Status of HIV-1 Vaccines. Vaccines 9:9, pages 1026.
Crossref
Mathew Daniel, Binhua Liang & Ma Luo. (2021) Assessment of the population coverage of an HIV-1 vaccine targeting sequences surrounding the viral protease cleavage sites in Gag, Pol, or all 12 protease cleavage sites. Vaccine 39:19, pages 2676-2683.
Crossref
Christopher P Karch, Peter Burkhard, Gary R Matyas & Zoltan Beck. (2021) The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back. Nanomedicine 16:8, pages 673-680.
Crossref
Meera V Singh, Sumanun Suwunnakorn, Sydney R Simpson, Emily A Weber, Vir B Singh, Pawel Kalinski & Sanjay B Maggirwar. (2021) Monocytes complexed to platelets differentiate into functionally deficient dendritic cells. Journal of Leukocyte Biology 109:4, pages 807-820.
Crossref
Sabrina Helmold Hait, Christopher James Hogge, Mohammad Arif Rahman, Ruth Hunegnaw, Zuena Mushtaq, Tanya Hoang & Marjorie Robert-Guroff. (2021) TFH Cells Induced by Vaccination and Following SIV Challenge Support Env-Specific Humoral Immunity in the Rectal-Genital Tract and Circulation of Female Rhesus Macaques. Frontiers in Immunology 11.
Crossref
Ajith Karawita. 2021. Atlas of Dermatoses in Pigmented Skin. Atlas of Dermatoses in Pigmented Skin 445 465 .
Kathrin U. Jansen, William C. Gruber, Raphael Simon, James Wassil & Annaliesa S. Anderson. 2021. Sustainable Agriculture Reviews 49. Sustainable Agriculture Reviews 49 347 430 .
Dean Sherry, Roland Worth & Yasien Sayed. 2022. Protein Reviews. Protein Reviews 79 108 .
Jelle A. Fok & Clemens Mayer. (2020) Genetic‐Code‐Expansion Strategies for Vaccine Development. ChemBioChem 21:23, pages 3291-3300.
Crossref
Véronique Godot, Colas Tcherakian, Laurine Gil, Iñaki Cervera-Marzal, Guangming Li, Liang Cheng, Nicolas Ortonne, Jean-Daniel Lelièvre, Giuseppe Pantaleo, Craig Fenwick, Mireille Centlivre, Hugo Mouquet, Sylvain Cardinaud, Sandra M. Zurawski, Gerard Zurawski, Pierre Milpied, Lishan Su & Yves Lévy. (2020) TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice. PLOS Pathogens 16:11, pages e1009025.
Crossref
Gillie A. Roth, Emily C. Gale, Marcela Alcántara-Hernández, Wei Luo, Eneko Axpe, Rohit Verma, Qian Yin, Anthony C. Yu, Hector Lopez Hernandez, Caitlin L. Maikawa, Anton A. A. Smith, Mark M. Davis, Bali Pulendran, Juliana Idoyaga & Eric A. Appel. (2020) Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity. ACS Central Science 6:10, pages 1800-1812.
Crossref
Shekoufa Jahedian, Seyed Mehdi Sadat, Gholam Reza Javadi & Azam Bolhassani. (2020) Production and Evaluation of the Properties of HIV-1-Nef-MPER-V3 Fusion Protein Harboring IMT-P8 Cell Penetrating Peptide. Current HIV Research 18:5, pages 315-323.
Crossref
Mona Sadat Larijani, Mohammad Hassan Pouriayevali, Seyed Mehdi Sadat & Amitis Ramezani. (2020) Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles. Current Drug Delivery 17:5, pages 387-395.
Crossref
Sergey Ivanov, Alexey Lagunin, Dmitry Filimonov & Olga Tarasova. (2020) Network-Based Analysis of OMICs Data to Understand the HIV–Host Interaction. Frontiers in Microbiology 11.
Crossref
Alan D. CurtisIIII, Maria Dennis, Joshua Eudailey, Korey L. Walter, Kenneth Cronin, S. Munir Alam, Neelima Choudhary, Ryan H. Tuck, Michael Hudgens, Pamela A. Kozlowski, Justin Pollara, Guido Ferrari, Koen K. A. Van Rompay, Sallie Permar & Kristina De Paris. (2020) HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy. mSphere 5:2.
Crossref
Chringma Sherpa & Stuart F.J. Le Grice. (2020) Adeno-Associated Viral Vector Mediated Expression of Broadly- Neutralizing Antibodies Against HIV-Hitting a Fast-Moving Target. Current HIV Research 18:2, pages 114-131.
Crossref
Rongyuan Gao, Zizhang Sheng, Chithra C. Sreenivasan, Dan Wang & Feng Li. (2020) Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function. Viruses 12:3, pages 276.
Crossref
Bartek Nogal, Matteo Bianchi, Christopher A. Cottrell, Robert N. Kirchdoerfer, Leigh M. Sewall, Hannah L. Turner, Fangzhu Zhao, Devin Sok, Dennis R. Burton, Lars Hangartner & Andrew B. Ward. (2020) Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines. Cell Reports 30:11, pages 3755-3765.e7.
Crossref
Yongjun Sui & Jay A. Berzofsky. (2020) Myeloid Cell-Mediated Trained Innate Immunity in Mucosal AIDS Vaccine Development. Frontiers in Immunology 11.
Crossref
Sivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernandez, Kannan Thiruvengadam, Sathyamurthi Pattabiram, Manohar Nesakumar, Ashokkumar Srinivasan, Sujitha Kathirvel, Janani Shankar, Rajat Goyal, Nikhil Singla, Joyeeta Mukherjee, Shweta Chatrath, Jill Gilmour, Sudha Subramanyam, Srikanth Prasad Tripathy, Soumya Swaminathan & Luke Elizabeth Hanna. (2020) Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in India. PLOS ONE 15:2, pages e0229461.
Crossref
Giovanna Meza, Almudena Expósito, José L. Royo, Celia Ruiz-García, Beatriz Sánchez-Arcas, Francisco J. Marquez, María A. Gómez-Vidal, Mohamed Omar, Faruk Sinangil, Keith Higgins, Donald Forthal, Luis M. Real & Antonio Caruz. (2020) Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine. AIDS 34:1, pages 25-32.
Crossref
Aliona S Rosca, Joana Castro, Lúcia G V Sousa & Nuno Cerca. (2020) Gardnerella and vaginal health: the truth is out there . FEMS Microbiology Reviews 44:1, pages 73-105.
Crossref
Stefanie Thalhauser, David Peterhoff, Ralf Wagner & Miriam Breunig. (2020) Critical design criteria for engineering a nanoparticulate HIV-1 vaccine. Journal of Controlled Release 317, pages 322-335.
Crossref
David W. Pantalone, Ian W. Holloway, Alison E. A. Goldblatt, Kaitlyn R. Gorman, Cara Herbitter & Christian Grov. (2019) The Impact of Pre-Exposure Prophylaxis on Sexual Communication and Sexual Behavior of Urban Gay and Bisexual Men. Archives of Sexual Behavior 49:1, pages 147-160.
Crossref
Valentina Marchese, Sarah Dal Zoppo, Virginia Quaresima, Benedetta Rossi & Alberto Matteelli. 2020. Sexually Transmitted Infections. Sexually Transmitted Infections 87 104 .
Joshua A. Salomon. (2019) Integrating Economic Evaluation and Implementation Science to Advance the Global HIV Response. JAIDS Journal of Acquired Immune Deficiency Syndromes 82:3, pages S314-S321.
Crossref
Peter Dull, Martin Friede, Angela Hwang & B. Fenton Hall. (2019) Meeting report: Global vaccine and immunization research forum, 2018. Vaccine 37:52, pages 7519-7526.
Crossref
Indra Sarabia & Alberto Bosque. (2019) HIV-1 Latency and Latency Reversal: Does Subtype Matter?. Viruses 11:12, pages 1104.
Crossref
Irene Yankellow & Charles T. Yingling. (2019) Nonoccupational Postexposure Prophylaxis: An Essential Tool for HIV Prevention. The Journal for Nurse Practitioners 15:10, pages 764-771.
Crossref
Prisca K. Thami & Emile R. Chimusa. (2019) Population Structure and Implications on the Genetic Architecture of HIV-1 Phenotypes Within Southern Africa. Frontiers in Genetics 10.
Crossref
Jian Liu, Dabbu Kumar Jaijyan, Qiyi Tang & Hua Zhu. (2019) Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8+ T-Cell Response. International Journal of Molecular Sciences 20:18, pages 4457.
Crossref
Abdulbaset Mazarzaei, Mahtab Vafaei, Abdolmajid Ghasemian, Seyede Amene Mirforughi, Hassan Rajabi Vardanjani & Nada A. S. Alwan. (2019) Memory and CAR‐NK cell‐based novel approaches for HIV vaccination and eradication. Journal of Cellular Physiology 234:9, pages 14812-14817.
Crossref
Philip K. Ehrenberg, Shida Shangguan, Biju Issac, Galit Alter, Aviva Geretz, Taisuke Izumi, Christopher Bryant, Michael A. Eller, Frank Wegmann, Richard AppsMatthew Creegan, Diane L. Bolton, Rafick P. Sekaly, Merlin L. Robb, Robert A. Gramzinski, Maria G. Pau, Hanneke Schuitemaker, Dan H. Barouch, Nelson L. Michael & Rasmi Thomas. (2019) A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials. Science Translational Medicine 11:507.
Crossref
Iris Valdés, Laura Lazo, Lisset Hermida, Gerardo Guillén & Lázaro Gil. (2019) Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?. Frontiers in Immunology 10.
Crossref
Andrey P. Rudometov, Anton N. Chikaev, Nadezhda B. Rudometova, Denis V. Antonets, Alexander A. Lomzov, Olga N. Kaplina, Alexander A. Ilyichev & Larisa I. Karpenko. (2019) Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope. Vaccines 7:3, pages 83.
Crossref
Blythe Adamson, Louis Garrison, Ruanne V Barnabas, Josh J Carlson, James Kublin & Dobromir Dimitrov. (2019) Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA. Journal of the International AIDS Society 22:8.
Crossref
Binhua Liang, Hongzhao Li, Lin Li, Robert Were Omange, Yan Hai & Ma Luo. (2019) Current advances in HIV vaccine preclinical studies using Macaque models. Vaccine 37:26, pages 3388-3399.
Crossref
Samantha Burton, Lori M. Spicer, Tysheena P. Charles, Sailaja Gangadhara, Pradeep B. J. Reddy, Tiffany M. Styles, Vijayakumar Velu, Sudhir Pai Kasturi, Traci Legere, Eric Hunter, Bali Pulendran, Rama Amara, Peter Hraber & Cynthia A. Derdeyn. (2019) Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants. Journal of Virology 93:7.
Crossref
Larisa I. Karpenko, Sergei I. Bazhan, Alexey M. Eroshkin, Denis V. Antonets, Anton N. Chikaev & Alexander A. Ilyichev. 2018. Advances in HIV and AIDS Control. Advances in HIV and AIDS Control.
Quang N. Nguyen, David R. Martinez, Jonathon E. Himes, R. Whitney Edwards, Qifeng Han, Amit Kumar, Riley Mangan, Nathan I. Nicely, Guanhua Xie, Nathan Vandergrift, Xiaoying Shen, Justin Pollara & Sallie R. Permar. (2018) Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys. Retrovirology 15:1.
Crossref
Franco Pissani, Bianca Schulte, Michael A. Eller, Bruce T. Schultz, Silvia Ratto-Kim, Mary Marovich, Prasert Thongcharoen, Somchai Sriplienchan, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Stefan Esser, Galit Alter, Merlin L. Robb, Jerome H. Kim, Nelson L. Michael & Hendrik Streeck. (2018) Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans. Journal of Virology 92:23.
Crossref
Enxiang Pan, Fengling Feng, Pingchao Li, Qing Yang, Xiuchang Ma, Chunxiu Wu, Jin Zhao, Hongbin Yan, Rulei Chen, Ling Chen & Caijun Sun. (2018) Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys. Frontiers in Immunology 9.
Crossref
Ali Ahmad, Vikram Mehraj, Mohammad-Ali Jenabian, Jean-Pierre Routy & Cecile Tremblay. (2018) Anti-Gag antibodies gag HIV infection and slow disease progression. AIDS 32:10, pages 1373-1375.
Crossref
Siriwat Akapirat, Chitraporn Karnasuta, Sandhya Vasan, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sirinan Madnote, Hathairat Savadsuk, Surawach Rittiroongrad, Jiraporn Puangkaew, Sanjay Phogat, James Tartaglia, Faruk Sinangil, Mark S. de Souza, Jean-Louis Excler, Jerome H. Kim, Merlin L. Robb, Nelson L. Michael, Viseth Ngauy, Robert J. O'Connell & Nicos Karasavvas. (2018) Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations. PLOS ONE 13:4, pages e0196397.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.